United Kingdom AI Diagnostics and Community Diagnostic Centres Market Research Report – Segmented by Diagnostic Modality (Imaging AI Diagnostics, Pathology & Laboratory AI Diagnostics, Cardiology AI Diagnostics, Respiratory AI Diagnostics, Ophthalmology AI Diagnostics, Neurology AI Diagnostics, Others); by Deployment Environment (Community Diagnostic Centres (CDCs), NHS Acute Hospital Diagnostic Hubs, Primary Care Diagnostic Networks, Independent Diagnostic Centres, Mobile & Outreach Diagnostic Units, Others); by Technology Type (Computer Vision AI, Machine Learning & Predictive Analytics, Natural Language Processing, Clinical Decision Support AI, Generative AI for Diagnostic Workflow, Others); by Clinical Care Pathway (Cancer Diagnostics, Cardiovascular Diagnostics, Respiratory Diagnostics, Neurological Diagnostics, Musculoskeletal Diagnostics, Women's Health Diagnostics, General Preventive & Screening Diagnostics, Others); by Revenue Model (Software Licensing, Software-as-a-Service (SaaS), Per-Scan/Per-Test Usage Fees, Managed Diagnostic Services, Outcome-Based & Value-Based Contracts, Others) ; and Region - Size, Share, Growth Analysis | Forecast (2026– 2030)